Displaying 1-12 of 12 result(s).
| Board Name | Posts By rspenc111 | Post Created |
|---|---|---|
| ONCS OncoSec Medical Incorporated | Any news coming out soon? Feels l | 02/05/2013 9:24:47 AM |
| CDMO Avid Bioservices, Inc. | up 11% today... didn't see any ne | 02/01/2013 3:59:39 PM |
| EDAP EDAP TMS S.A. | Up 10% today! EDAP Submits U.S. FDA | 02/01/2013 10:18:42 AM |
| IMNN Imunon, Inc. | Trading was halted for afterhours, | 01/30/2013 11:11:21 PM |
| ETRM EnteroMedics Inc. | Anyone have an opinion about upcomi | 01/30/2013 3:31:21 PM |
| IMNN Imunon, Inc. | Now that is hilarious! | 01/28/2013 10:33:53 PM |
| IMNN Imunon, Inc. | LOL | 01/28/2013 9:41:10 PM |
| IMNN Imunon, Inc. | Clsn down in after hours tonight. D | 01/28/2013 8:58:55 PM |
| IMNN Imunon, Inc. | Thanks! I have been noticing what | 01/28/2013 10:07:41 AM |
| IMNN Imunon, Inc. | Just saw ETRM mentioned. Any opin | 01/28/2013 9:45:07 AM |
| IMNN Imunon, Inc. | What do you think strategy should b | 01/27/2013 3:30:16 PM |
| IMNN Imunon, Inc. | Anyone surprised there wasn't one l | 01/25/2013 3:33:29 PM |
Recent Articles
- Afarak Group Reports Significant Changes in Production Metrics
- Exciting Insights Await at AS Tallinna Vesi's Upcoming Webinar
- NB Private Equity Partners Shares Buyback Details Released
- JLT Mobile Computers Reports Growth in Interim Results 2025
- Faraday Future Partners with RAK Motors for UAE Expansion
- Nanobiotix Advances JNJ-1900 (NBTXR3) Program Updates
- Dan Ives Highlights Tesla's Robotaxi Future as Uber Faces Pressure
- Munters Group AB: Focus on Growth in Data and Food Technologies
- Duni Group Enhances Growth and Sustainability Targets for Future
- Exploring the Growth of the Glass-Reinforced Substrate Market
- OSB Group PLC Engages in Share Buyback Initiative
- Bank of Åland Reports Strong Growth in Financial Performance
- Important Share Conversion Announcement from Orion Corporation
- Latest Developments and Updates from TEXAF Group
- NANOBIOTIX Advances JNJ-1900 Insights and Collaborations
- Nilörn Reports Strong Q3 2025 Performance and Growth Figures
- Foresight Group Holdings' Share Buyback Success Announced
- AKVA Group ASA: Insights Await as Q3 2025 Results Unveiled
- ICG Enterprise Trust Highlights Successful Realisation of Froneri
- Wendel's Strategic Moves: Key Developments and Financial Insights
- Wendel Initiates Strategic Acquisition of Committed Advisors
- Hiab's Q3 2025 Report: Navigating Lower Sales Impact
- Faraday Future Partners with RAK Motors to Launch FX Super One
- ONWARD Medical Secures EUR 50 Million for Neurotech Expansion
- Wellgistics Health Stock Gains Significantly from New Deal
- Cathie Wood Backs Quantum Solutions: A New ETH Investment Wave
- Sivers Semiconductors Reports Strong Q3 Performance with Growth
- Saab's Performance in Q3 2025: A Path to Continued Growth
- Hiab's Q3 2025 Update: Adapting to Market Dynamics
- Saab Reports Impressive Growth in Q3 2025 Performance
- ONWARD Medical Secures Significant Capital for Growth Ahead
- Sanofi Reports Strong Q3 Sales Growth and Positive Developments
- Sampo plc's Strategic Share Buyback Program Insights
- Exploring Bank of Åland Plc's 2026 Financial Plans and Meeting
- Sanofi's Q3 Report Highlights Strong Sales and Earnings Growth
- Sanofi Reports Strong Q3 Earnings and Sales Growth
- Sivers Semiconductors Reports Dynamic Q3 Performance for 2025
- Experience the All-New G700: Redefining Hybrid Off-Road Driving
- Hiab's Q3 Report 2025: Navigating Challenges with Resilience
- Signify Delivers Mixed Q3 Results with Strong Cash Flow and Strategy
- Norsk Hydro's Financial Performance in a Challenging Market
- Hiab Reports Decrease in Profitability Amid US Sales Decline
- Nokia and VNPT Join Forces to Enhance Vietnam's Digital Connectivity
- Signify's Q3 2025: Navigating Challenges with Resilience
- Norsk Hydro's Resilience Amid Market Challenges: A Detailed Overview
- DNO ASA's Hybrid Bonds Approved for Oslo Stock Exchange Trading
- NHK World Highlights Blue Economy Collaboration with Africa
- Innovative Driving Experience with LEPAS: A Hands-On Journey
- LEPAS Fun Drive Event Emphasizes User Experience and Innovation
- X4 Pharmaceuticals Unveils $135 Million Stock Offering Plans